• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • MF Shareholding
  • Similar Stocks
  • News
  • FAQs

    • Nureca Share PriceNureca

    Small Cap 2.1k
    ₹320.05
    0.1 (0.03%)
    As on 28 March, 2023 | 08:37 BSE: 543264 NSE: NURECA

    Nureca Performance

    Day Range

    • Low
    • High

    52 Week Range

    • Low
    • High
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Nureca

    Start SIP

    Nureca Share Price

    • Over 1 Month -6.23%
    • Over 3 Month -36.22%
    • Over 6 Month -63.91%
    • Over 1 Year -76.84%

    Nureca Key Statistics

    P/E Ratio -39.4
    PEG Ratio 0.3
    Market Cap Cr 320
    Price to Book Ratio 1.6
    EPS 44.8
    Dividend 0
    Relative Strength Index 38.14
    Money Flow Index 47.02
    MACD Signal -15.68
    Average True Range 17.97

    Nureca F&O

    Nureca Futures
    Nureca Options

    Nureca Investment Rating

    • Master Rating:

    • Nureca has an operating revenue of Rs. 131.15 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 24% is great, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 10 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 169 indicates it belongs to a poor industry group of Medical-Products and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Nureca Financials
    IndicatorDec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 28372641
    Operating Expenses Qtr Cr 29423244
    Operating Profit Qtr Cr -1-5-5-3
    Depreciation Qtr Cr 1111
    Interest Qtr Cr 0000
    Tax Qtr Cr 0-1-1-1
    Net Profit Qtr Cr 0-3-4-1

    Nureca Technicals

    EMA & SMA

    Current Price
    ₹320.05
    0.1 (0.03%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • 336.69
    • 50 Day
    • 379.07
    • 100 Day
    • 481.86
    • 200 Day
    • 679.47
    • 20 Day
    • 336.85
    • 50 Day
    • 364.27
    • 100 Day
    • 461.15
    • 200 Day
    • 712.04

    Nureca Resistance and Support

    PIVOT
    ₹327.57
    Resistance
    First Resistance 337.14
    Second Resistance 354.32
    Third Resistance 363.89
    RSI 38.14
    MFI 47.02
    MACD Single Line -15.68
    MACD -14.72
    Support
    First Resistance 310.39
    Second Resistance 300.82
    Third Resistance 283.64

    Nureca Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 50,954 2,226,180 43.69
    Week 104,600 3,497,811 33.44
    1 Month 66,199 2,351,394 35.52
    6 Month 347,196 5,891,924 16.97

    Nureca Result Highlights

    Nureca Synopsis

    NSE-Medical-Products

    Nureca Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 255.55 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2022. Nureca Ltd. is a Public Limited Listed company incorporated on 02/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24304MH2016PLC320868 and registration number is 320868.
    Market Cap 321
    Sales 132
    Shares in Float 0.37
    No of funds 6
    Yield 0.94
    Book Value 1.57
    U/D Vol ratio 3.8
    LTDebt / Equity 2
    Alpha -0.53
    Beta 1

    Nureca

    Owner NameDec-22Sep-22Jun-22Mar-22
    Promoters 62.98%70%70%
    Mutual Funds 1.35%
    Foreign Portfolio Investors 0.1%1.67%12.04%
    Financial Institutions/ Banks 0.55%3.88%
    Individual Investors 34.17%25.85%8.54%
    Others 2.75%1.93%4.19%

    Nureca Management

    Name Designation
    Mr. Saurabh Goyal Chairman & Managing Director
    Mr. Aryan Goyal WholeTime Director & CEO
    Mr. Rajinder Sharma Whole Time Director
    Mrs. Charu Singh Independent Director
    Mrs. Ruchita Agarwal Independent Director
    Mr. Vijay Kumar Sharma Independent Director
    Dr. Vikram Chaudhery Independent Director
    Mr. Nitin Ravindra Bidikar Independent Director
    Dr. Shrikant Uttam Tamhane Independent Director

    Nureca Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Nureca MF Shareholding

    Name Amount(cr)
    Motilal Oswal S&P BSE Healthcare ETF 6

    Nureca FAQs

    What is Share Price of Nureca ?

    Nureca share price is ₹320 As on 28 March, 2023 | 08:23

    What is the Market Cap of Nureca ?

    The Market Cap of Nureca is ₹320.1 Cr As on 28 March, 2023 | 08:23

    What is the P/E ratio of Nureca ?

    The P/E ratio of Nureca is -39.4 As on 28 March, 2023 | 08:23

    What is the PB ratio of Nureca ?

    The PB ratio of Nureca is 1.6 As on 28 March, 2023 | 08:23

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from NSDL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.

    Start Investing Now!

    Open Free Demat Account in 5 mins

    Enter Valid Mobile Number